Longitudinal association between IGFBP-1 levels and parameters of the metabolic syndrome in obese children before and after weight loss

References

• Reaven GM. Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease. Am Heart J. 1991;121(4 Pt 2):1283–8.
   PubMedGoogle Scholar
• Marion AW, Baker AJ, Dhawan A. Fatty liver disease in children. Arch Dis Child. 2004;89(7):648–52.
   PubMedGoogle Scholar
• Eyzaguirre F, Mericq V. Insulin resistance markers in children. Horm Res. 2009;71(2):65–74.
   PubMedGoogle Scholar
• Lee JM, Kim SR, Yoo SJ . The Relationship between Adipokines, Metabolic Parameters and Insulin Resistance in Patients with Metabolic Syndrome and Type 2 Diabetes. J Int Med Res. 2009;37(6):1803–12.
   PubMedGoogle Scholar
• Lebensztejn DM, Wojtkowska M, Skiba E . Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease. Adv Med Sci. 2009;54(2):177–82.
   PubMedGoogle Scholar
• Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 2002;23(6): 824–54.
   PubMedGoogle Scholar
• Conover CA, Lee PD, Kanaley JA . Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab. 1992; 74(6):1355–60.
   PubMedGoogle Scholar
• Kamoda T, Saitoh H, Inudoh M . The serum levels of proinsulin and their relationship with IGFBP-1 in obese children. Diabetes Obes Metab. 2006;8(2):192–6.
   PubMedGoogle Scholar
• Nam SY, Lee EJ, Kim KR . Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord. 1997;21(5):355–9.
   PubMedGoogle Scholar
• Ono M, Chia DJ, Merino-Martinez R . Signal transducer and activator of transcription (Stat) 5b-mediated inhibition of insulin-like growth factor binding protein-1 gene transcription: a mechanism for repression of gene expression by growth hormone. Mol Endocrinol. 2007;21(6):1443–57.
   PubMedGoogle Scholar
• Park MJ, Kim HS, Kang JH . Serum levels of insulin-like growth factor (IGF)-I, free IGF-I, IGF binding protein (IGFBP)-1, IGFBP-3 and insulin in obese children. J Pediatr Endocrinol Metab. 1999;12(2):139–44.
   PubMedGoogle Scholar
• Saitoh H, Kamoda T, Nakahara S . Insulin-like growth factor binding protein-1 as a predictor of glucose-stimulated hyperinsulinemia in prepubertal obese children. Eur J Endocrinol. 1999;140(3):231–4.
   PubMedGoogle Scholar
• Travers SH, Labarta JI, Gargosky SE . Insulin-like growth factor binding protein-I levels are strongly associated with insulin sensitivity and obesity in early pubertal children. J Clin Endocrinol Metab. 1998;83(6):1935–9.
   PubMedGoogle Scholar
• Wabitsch M, Blum WF, Muche R . Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls. Int J Obes Relat Metab Disord. 1996;20(12):1073–80.
   PubMedGoogle Scholar
• Liew CF, Wise SD, Yeo KP . Insulin-like growth factor binding protein-1 is independently affected by ethnicity, insulin sensitivity, and leptin in healthy, glucose-tolerant young men. J Clin Endocrinol Metab. 2005;90(3):1483–8.
   PubMedGoogle Scholar
• Attia N, Tamborlane WV, Heptulla R . The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab. 1998;83(5): 1467–71.
   PubMedGoogle Scholar
• I’Allemand D, Wiegand S, Reinehr T . Cardiovascular risk in 26,008 European overweight children as established by a multicenter database. Obesity (Silver Spring). 2008;16 (7):1672–9.
   PubMedGoogle Scholar
• Kromeyer-Hauschild K, Wabitsch M, Geller F . Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderheilkd. 2001;149:807–18.
   Web of Science ®Google Scholar
• Cole TJ, Bellizzi MC, Flegal KM . Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320(7244):1240–3.
   PubMed Web of Science ®Google Scholar
• Reinehr T, de Sousa G, Toschke AM . Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention. Am J Clin Nutr. 2006;84(3):490–6.
   PubMedGoogle Scholar
• American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease. Gastroenterology. 2002;123(5):1702–4.
   PubMedGoogle Scholar
• Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed). 1986;292(6512):13–5.
   PubMedGoogle Scholar
• Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr. 1990;44:45–60.
   PubMed Web of Science ®Google Scholar
• National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555–76.
   PubMed Web of Science ®Google Scholar
• Lassarre C, Binoux M. Measurement of intact insulin-like growth factor-binding protein-3 in human plasma using a ligand immunofunctional assay. J Clin Endocrinol Metab. 2001;86(3):1260–6.
   PubMedGoogle Scholar
• Matthews DR, Hosker JP, Rudenski AS . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.
   PubMed Web of Science ®Google Scholar
• Zimmet P, Alberti KG, Kaufman F . The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes. 2007;8(5):299–306.
   PubMedGoogle Scholar
• Kromeyer-Hausschild K, Gläßer N, Zellner K. Waist Circumference percentile in Jena children (Germany) 6 to 18 years of age. Aktuel Ernaehr Med. 2008;33:116–22.
   Google Scholar
• Baxter RC, Martin JL. Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res. 1989;1(1):49–68.
   PubMedGoogle Scholar
• Lewitt MS, Baxter RC. Regulation of growth hormone-independent insulin-like growth factor-binding protein (BP-28) in cultured human fetal liver explants. J Clin Endocrinol Metab. 1989;69(2):246–52.
   PubMedGoogle Scholar
• Yoshinaga M, Sameshima K, Tanaka Y . Adipokines and the prediction of the accumulation of cardiovascular risk factors or the presence of metabolic syndrome in elementary school children. Circ J. 2008;72(11):1874–8.
   PubMedGoogle Scholar
• Cizmecioglu FM, Etiler N, Ergen A . Association of adiponectin, resistin and high sensitive CRP level with the metabolic syndrome in childhood and adolescence. Exp Clin Endocrinol Diabetes. 2009;117(10):622–7.
   PubMedGoogle Scholar
• Petersson U, Ostgren CJ, Brudin L . Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Soderakra Cardiovascular Risk Factor Study. Diabetes Metab. 2009; 35(3):198–205.
   PubMedGoogle Scholar
• Schober E, Holl RW, Grabert M . Diabetes mellitus type 2 in childhood and adolescence in Germany and parts of Austria. Eur J Pediatr. 2005;164(11):705–7.
   PubMedGoogle Scholar
• LeRoith D, McGuinness M, Shemer J . Insulin-like growth factors. Biol Signals. 1992;1(4):173–81.
   PubMedGoogle Scholar
• Copeland KC, Colletti RB, Devlin JT . The relationship between insulin-like growth factor-I, adiposity, and aging. Metabolism. 1990;39(6):584–7.
   PubMedGoogle Scholar
• Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab. 2006;17(8):328–36.
   PubMedGoogle Scholar
• Kotronen A, Lewitt M, Hall K . Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity. J Clin Endocrinol Metab. 2008;93(12): 4867–72.
   PubMedGoogle Scholar
• Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med. 2002;19(7):527–34.
   PubMedGoogle Scholar
• Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28(1):27–38.
   PubMedGoogle Scholar
• Uwaifo GI, Fallon EM, Chin J . Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care. 2002;25(11):2081–7.
   PubMedGoogle Scholar